Detailed clinical course of fatal acute encephalopathy in children.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 15 11 2018
revised: 29 03 2019
accepted: 16 04 2019
pubmed: 25 7 2019
medline: 17 1 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Although the mortality among previously healthy children with acute encephalopathy (AE) is approximately 5%, their detailed clinical course has not been clarified. The objective of the present study was to describe the detailed clinical course, in minutes, of fatal AE. We retrospectively reviewed the medical records of five patients (from 6 months to 14 years of age) who previously had no neurological disorders and were diagnosed with brain death due to AE between 2002 and 2018 at Kobe Children's Hospital. The initial clinical symptoms were convulsion in three cases and impaired consciousness in two. The earliest noted brain imaging abnormality was 7.5 h after neurological symptom detection. Liver enzymes and creatinine levels increased at initial examination, and sodium elevated gradually. All patients met the criteria of systemic inflammatory response syndrome, disseminated intravascular coagulation, and shock within 14 h of symptom detection. High dose steroids and targeted temperature management were initiated 3.5-14 h after onset. Despite these therapies, patients were diagnosed with brain death from 16 h to 4 days after initial neurological symptoms. AE diagnoses were made between 4 h 29 min and 4 days after initial neurological symptoms and included hemorrhagic shock and encephalopathy syndromes, Reye-like syndrome, and acute necrotizing encephalopathy in two, two, and one patient(s), respectively. We revealed the time series' of clinical events (e.g. SIRS, shock, DIC, AE diagnosis, brain death, and treatments) and laboratory findings relative to initial neurological symptom in fatal AE.

Identifiants

pubmed: 31337523
pii: S0387-7604(18)30555-2
doi: 10.1016/j.braindev.2019.04.012
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-698

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Kazumi Tomioka (K)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: toimoka@med.kobe-u.ac.jp.

Masahiro Nishiyama (M)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Hiroaki Nagase (H)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Yusuke Ishida (Y)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Tsukasa Tanaka (T)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Shoichi Tokumoto (S)

Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Hiroshi Yamaguchi (H)

Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Daisaku Toyoshima (D)

Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Azusa Maruyama (A)

Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Kyoko Fujita (K)

Department of Emergency and General Medicine, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Kazunori Aoki (K)

Department of Pediatric Critical Care Medicine, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Yusuke Seino (Y)

Department of Pediatric Critical Care Medicine, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Kandai Nozu (K)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Noriyuki Nishimura (N)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Hiroshi Kurosawa (H)

Department of Pediatric Critical Care Medicine, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

Kazumoto Iijima (K)

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH